Insiders Lexaria Bioscience Corp.

Equities

LEXX

US52886N4060

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-13 EDT			5-day change	1st Jan Change
3.18 ^USD	-10.42%		-6.74%	+154.40%

05-08	Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study	CI
04-16	Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexaria Bioscience Names Nelson Cabatuan as Finance Chief	03-14	MT
Lexaria Bioscience Appoints Mike Shankman as CFO	23-06-12	MT
Lexaria Bioscience Corp. Appoints Chris Bunka as Principal Financial Officer	23-06-12	CI
Lexaria Bioscience Corp. Appoints Julian Gangolli as Strategic Advisor	23-01-23	CI
Lexaria Bioscience Corp. Appoints Dr. Catherine Turkel to its Board of Directors	22-09-02	CI
Brian Quigley Will Not Stand for Re-Election of Lexaria Bioscience Corp.'s Board	21-06-30	CI
Lexaria Bioscience Corp. Elects Ted Mckechnie as A Director	21-06-29	CI
Brian Quigley, Director of Lexaria Bioscience Corp. Determines Not to Stand for Re-Election	21-05-14	CI
Lexaria Bioscience Corp. Appoints Gregory Downey as Chief Financial Officer	21-04-15	CI
Lexaria Bioscience : DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network	21-04-14	PU
Lexaria Bioscience : DehydraTECH(TM) Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network	21-04-14	AQ
Lexaria Bioscience Corp. Appoints Al Reese as Board of Director	21-01-14	CI
Lexaria Bioscience Corp. Appoints Gregg Smith, Founder of Evolution VC Partners, as Senior Advisor	19-11-05	CI
Lexaria Bioscience Corp. Appoints Brian Quigley to its Board of Directors	19-08-14	CI
Lexaria Bioscience Corp. Elects Ted Mckechnie as Director	19-06-21	CI
Lexaria Bioscience Corp. Expands Advisory Board	19-04-25	CI
Lexaria Bioscience Submits Application to Health Canada for Research License; Appoints Ed Ergenzinger as Chief Legal Officer and Senior Vice President of Innovation	18-11-28	CI
Lexaria Bioscience Corp Appoints Allan Spissinger as New Acting CFO, Secretary and Treasurer	17-06-05	CI
Lexaria Corp. will Change its Name to Lexaria Bioscience Corp	16-05-12	CI
Lexaria Corp. Announces Executive Changes	16-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lexaria Bioscience Corp.

Equities

LEXX

US52886N4060

Insiders

Filters